T40.725S — Adverse effect of synthetic cannabinoids, sequela
Is T40.725S billable?
Yes — T40.725S is billable for FY2027. T40.725S is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. T40.725S may be submitted for encounters from October 1, 2026 through September 30, 2027.
T40.725S at a glance
| Code | T40.725S |
|---|---|
| Description | Adverse effect of synthetic cannabinoids, sequela |
| Billable | Yes |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
| 7th character "S" | sequela |
What does the 7th character "S" mean in T40.725S?
In T40.725S, the 7th character S means sequela. The 7th character is required for T40.725S to be a valid, complete code.
Same condition, different episode of care — switch the 7th character:
What Medicare edits apply to T40.725S?
The Medicare Code Editor screens inpatient claims before they are grouped. These edits name T40.725S directly.
CMS will reject this code as the principal diagnosis on an inpatient claim. It describes something other than the condition chiefly responsible for the admission.
Which MS-DRGs does T40.725S group to?
T40.725S sits in MDC 21 and helps define the logic of 2 MS-DRGs (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.
- 922Other Injury, Poisoning and Toxic Effect Diagnoses with MCCmedical
- 923Other Injury, Poisoning and Toxic Effect Diagnoses without MCCmedical
Excludes1 — never code together — inherited from T36-T50
The conditions below can never be reported together with T40.725S on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.
- toxic reaction to local anesthesia in pregnancy (O29.3-)
Code first — inherited from T36-T50
The underlying condition below must be sequenced before T40.725S. T40.725S describes a manifestation and cannot be the principal or first-listed diagnosis.
Use additional code — inherited from Chapter 19
Report an additional code alongside T40.725S to fully describe the condition. T40.725S is sequenced first.
- code to identify any retained foreign body, if applicable (Z18.-)
Use additional code — inherited from T36-T50
Report an additional code alongside T40.725S to fully describe the condition. T40.725S is sequenced first.
Excludes2 — not included here — inherited from Chapter 19
The conditions below are not part of T40.725S, but a patient may have both at the same time. When documentation supports it, T40.725S and the excluded code may both be reported.
Excludes2 — not included here — inherited from T36-T50
The conditions below are not part of T40.725S, but a patient may have both at the same time. When documentation supports it, T40.725S and the excluded code may both be reported.
Excludes2 — not included here — inherited from T40
The conditions below are not part of T40.725S, but a patient may have both at the same time. When documentation supports it, T40.725S and the excluded code may both be reported.
- drug dependence and related mental and behavioral disorders due to psychoactive substance use (F10.-F19.-)
How long has T40.725S existed?
T40.725S first appears in FY2022.
Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.